JCVI backs immediate expansion of COVID-19 vaccination to combat Omicron variant

The COVID-19 booster campaign should expand immediately to people aged 18-39 and second doses should be offered to those aged 12-15, under JCVI advice updated in response to the Omicron variant.

JCVI COVID-19 immunisation chair Professor Wei Shen Lim (Photo: JustinTallis/Getty Images)

Updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) says eligibility for booster doses of COVID-19 vaccine should expand immediately to all adults aged 18 to 39 years old.

The updated advice says booster vaccination - with either the Pfizer or Moderna vaccines - should continue to be rolled out 'in order of descending age groups' and prioritising those in at-risk groups, but shortens the timescale within which booster doses can be offered.

Plans to expand the booster campaign come as GP leaders appeal to ministers to reduce administrative pressure on general practice to allow a greater focus on the vaccination campaign.

COVID-19 booster vaccination

Booster doses should not be given 'within three months of completion of the primary course' of COVID-19 vaccination, the advice says - halving the previous recommendation that boosters should take place six months after primary vaccination.

Patients with severe immunosuppression who have received three doses as part of their primary course can also be offered a booster jab three months after their third dose.

The JCVI has also recommended that all children and young people aged 12 to 15 years old should be offered a second dose of the Pfizer COVID-19 vaccine 'at a minimum of 12 weeks from the first dose'.

It said that a reduction in the interval to eight weeks could be approved 'if the emerging epidemiological data supports this' - and that this shorter timeframe could also be applied for 16- to 17-year-olds.

A statement from the committee said: 'The overall intention of the measures advised above is to accelerate the deployment of COVID-19 vaccines before the peak of any impending Omicron wave.

Omicron infection

'There is currently no data to indicate that Omicron infection is associated with a change in the pattern of susceptibility to serious COVID-19 (hospitalisation and death). Persons of older age, or who are in COVID-19 at-risk groups are likely to remain at higher risk from serious COVID-19; therefore, vaccination should be prioritised accordingly.

'Continued efforts should be made to offer COVID-19 vaccination (first, second and booster doses) to adults who have yet to receive any COVID-19 vaccinations.'

Deputy CMO Professor Jonathan Van Tam told a Downing Street press conference: 'We don't know what is going to happen next. The next three weeks will be weeks of scientific uncertainty.

'While we wait for the mist to clear on what this concerning variant means, there is no time to delay. Vaccine boosting is the thing we can do most easily while we wait for the science mist to clear.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

RCGP sign at the college's annual conference

RCGP working group to explore implications of assisted dying law change

The RCGP is to set up a working group to look at the 'practical implications' of...


Abysmal access to testing leaves GPs 'guessing' on lung diagnosis, charity warns

GPs are being forced to make 'educated guesses' when diagnosing common lung conditions...

BMA Scotland GP committee chair Dr Andrew Buist

'Disappointing' uplift falls short of 6% pay rise promised to GPs in Scotland

A 'disappointing' uplift to contract funding worth £60.4m in 2023/24 will not deliver...

Person selecting medicine in a dispensary

Dispensing GPs demand funding overhaul to ensure services remain viable

Dispensing doctors have demanded improved representation in GP contract negotiations,...

GP consultation room

GPs seeing cases of malnutrition and rickets as cost-of-living crisis hits patient health

Three quarters of GPs are seeing a rise in patients with problems linked to the cost-of-living...

Female GP listening to a patient

What GPs need to know about changes to Good Medical Practice

Dr Udvitha Nandasoma, the MDU’s head of advisory services, explains what GPs need...